Abbott vs Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?
What it is about
Who published it, and when
2 reports left out of the cascade - too little in common with the story to place
How it spread - 5 original reports
Tue, 4 August 2026
1 report- yahoo.com16:55
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped ease investor concerns surrounding procedure volumes. Sales for the quarter rose 13% on a reported basis and 4.8% on a comparable basis. Danaher Corporation’s (NYSE:DHR) […]
Fri, 7 August 2026
2 reports- insidermonkey.com12:37
Matrix Asset Advisors, an asset management company, released its Q2 2026 investor letter. A copy of the letter can be downloaded here.
- fool.com20:24first to report
AbbVie generates stronger free cash flow and trades at a lower forward multiple, while Abbott offers diversification and a healthier balance sheet.
Sun, 16 August 2026
1 report- dailypolitical.com02:58
Waddell & Associates LLC raised its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 208.9% in the 2nd quarter, Holdings Channel reports. The firm owned 10,214 shares of the healthcare product maker’s stock after purchasing an additional 6,907 shares during the quarter. Waddell & Associates LLC’s holdings in Abbott Laboratories were worth […]
Mon, 24 August 2026
1 report- yahoo.com14:35
AbbVie and Abbott stand out as strong healthcare investments because they combine established businesses with long-term growth opportunities.